Viral Clearance Market

Viral Clearance Market Size

The global viral clearance market valued at USD 615 million in 2025, is project to reach USD 664 million in 2026 and USD 1,704 million by 2035, representing a higher CAGR of 11.0% during the forecast period 2026 to 2035.

Market Report: Key Takeaways

Market Size & Trends

• In terms of scale of operation, the clinical segment holds the highest share (more than 85%) of the market.
• With regards to method of viral clearance and testing, the viral removal segment dominates the global market with 55% market share.
• Based on the end users, the contract research organizations hold the largest market share (more than 30%) in 2026.
• In terms of geographical regions, North America captures the majority of the market share, and Europe is likely to grow at a faster pace in the near future.

Market Overview

Viral clearance and testing refer to the detection and elimination of viral contaminants using a wide array of methods, to ensure the product safety for human use. Over the past few years, viral clearance and testing has emerged as one of the key pre-requisites for biopharmaceutical regulatory approvals. It is worth mentioning that till date, over 630 biologics have already been approved by the Food and Drug Administration (FDA), while more than 8,000 biopharmaceuticals are in the clinical evaluation process. This increased number of approvals and ongoing clinical trials in the biopharmaceutical industry has resulted in an evident rise in the demand for such studies. 

However, virus removal, inactivation and detection requires specialized expertise as it is a complex, cost intensive, and time consuming process. Therefore, innovators are actively exploring avenues that would enable them to overcome the existing challenges. Among other alternatives, outsourcing these studies to service providers having FDA accredited laboratories has emerged as the most preferable option for most of the biopharmaceutical manufacturers.

Presently, a number of players across the globe are actively engaged in providing efficient viral clearance and testing services throughout the research and development process. Further, as more biologics enter into the development pipeline, the viral clearance market growth is anticipated to at a healthy CAGR.

Viral Clearance Market Trends

• Large Players have Undertaken Initiatives to Expand Capabilities: Some initiatives include strengthening their respective service portfolios, entering into strategic deals, and expanding their facility and capacity. The most recent collaboration was signed between France based GTP Bioways and Texcell in March 2023. The former is a CDMO for biologic manufacturing and Texcell is a CRO specializing in viral testing, viral clearance and bioassays. The partnership has created a one-stop solution for their clients, specifically biopharmaceutical companies for testing and manufacturing support during clinical development.
• Patent Trends: More than 260 patents, related to viral clearance and testing, have been filed / granted in the last few years. It is worth mentioning that most of the patents have been filed by industry players and are focused on viral removal methods and techniques. 

Market Share Insights

Market Share by Scale of Operation

• The global viral clearance market size is categorized across discovery, preclinical and clinical scale.
• As depicted in the bar chart below, the clinical segment holds the highest share (more than 85%) of the market.
• This is essentially the stage where majority of viral clearance studies and services are outsourced to CMOs and CDMOs.

Market Share by Key Geographical Regions

• Presently, more than 60% of the viral clearance market share is captured by laboratories based in North America and Europe.
• Asia-pacific is being looked at as a growth market for the viral clearance testing services, as the development and manufacturing of biologics and biosimilars is picking up in countries such as China and India.
• MilliporeSigma opened a biologics testing center in Shanghai, China in September 2022. The center has a viral clearance laboratory, set-up with the aim to meet the growing local demand for viral clearance testing services.

Key Market Insights

Benefits and Growing Demand for Viral Clearance Studies

Viral clearance and testing studies have emerged as a mandatory step for regulatory submissions of biologics, for commercial applications. These studies result in streamlined manufacturing of contamination free / safe products and on-time delivery of biologics. Owing to this, the demand for these services has increased significantly. It is worth highlighting that, with the continuous revision of the regulatory guidelines, viral clearance and testing studies are anticipated to become the most essential step in the biopharmaceutical manufacturing, including antibodies, blood products, cell and gene therapies, hormones, recombinant proteins, therapeutic proteins and vaccines.

Current Market Landscape of Viral Clearance Testing Service Providers

The viral clearance and testing service providers landscape features a mix of large, mid-sized and small companies, which have the required expertise to offer various services for the viral clearance and testing of biologics, across the manufacturing and purification stages. It is worth highlighting that majority of service providers are large companies. Further, recent developments in this segment of the biopharmaceutical industry indicate that the service providers are upgrading their capabilities and infrastructure to accommodate the current and anticipated demand for these services.

Viral Clearance Market Size Analysis

Viral clearance market for testing services is estimated to be worth USD 664 million in 2026. Driven by the rising interest in research and development activities and the demand for viral clearance testing services, the future opportunities and growth associated with this market are anticipated to witness a noteworthy growth in the foreseen future. The global market is anticipated to grow at a CAGR of 11.0% during the forecast period.

Specifically, in terms of end users, the market is anticipated to be driven by biotechnology and pharmaceutical companies.

Key Viral Clearance Testing Services Providers

Examples of key players engaged in this domain (which have also been captured in this report) include Charles River Laboratories, Creative Biolabs, Eurofins Scientific, Microbac Laboratories, MilliporeSigma, Nelson Labs, Syngene International, Texcell, Vironova and WuXi Biologics.

Market Segmentation Insights

Key Report Attributes

Frequently Asked Questions